Drug intelligence / Profile preview

Sorghum halepense pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous, Sublingual
01

Overview

Sorghum halepense pollen is an allergenic extract derived from Johnson grass (Sorghum halepense) pollen. [3] It is used for both allergy testing (diagnosis) and allergen-specific immunotherapy (hyposensitization therapy) to treat patients with allergic reactions to this specific pollen. [1, 17] Developed and marketed by ALK-Abelló, Inc., this non-standardized extract has been available since 1965. It is administered as a subcutaneous injection solution. [6] The product works by modulating the immune system to induce desensitization to the allergens present in Sorghum halepense pollen. [1] It is indicated for individuals with a confirmed clinical sensitivity to Johnson grass pollen, as determined by patient history and diagnostic skin testing, who suffer from conditions like allergic respiratory diseases. [8, 9]

Other names
Johnson grass pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Sorghum halepense pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorghum halepense pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call